• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Crescita Therapeutics Inc
Gibson Energy Inc
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exagen Inc. - Common Stock (NQ:XGN)

8.510 +0.170 (+2.04%)
Delayed Quote Updated: 4:00 PM EST, Nov 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 131,628
Open 8.520
Bid (Size) 7.030 (5,000)
Ask (Size) 9.250 (300)
Prev. Close 8.340
Today's Range 8.310 - 8.670
52wk Range 2.590 - 11.92
Shares Outstanding 16,126,784
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Exagen Inc. to Participate in Upcoming Investor Conferences
October 29, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen to Announce Third Quarter Financial Results on November 10, 2026
October 27, 2026
From Exagen Inc.
Via GlobeNewswire

Performance

52-Week Range 28.6% below 52-week high
8.510
2.5952W Low 11.9252W High
1 Week 4.2% below 1-week high
7.711W Low 8.881W High

Exagen Inc. - Common Stock (XGN) traded between $2.59 and $11.92 over the past 52 weeks and last traded at $8.51, 28.6% below its 52-week high. Over the past week it ranged between $7.71 and $8.88.

Past 12 Months
+1.3%
+0.6%
+31.9%
+175.4%
+40.9%
-28.1%
1W +$0.11
1M +$0.05
3M +$2.06
6M +$5.42
YTD +$2.47
1Y -$3.32

XGN was -28.1% over the past year, +175.4% over six months, +40.9% year to date, +1.3% in the last week.

12 Months vs Market
XGN
-28.1%
DIA
+12.6%
SPY
+12.2%
QQQ
+9.5%
IWM
+15.7%

Over the past 12 months XGN returned -28.1% versus DIA (Dow) +12.6%, SPY (S&P 500) +12.2%, QQQ (Nasdaq 100) +9.5% and IWM (Russell 2000) +15.7%.

Volume & Liquidity 0.36× 3-mo avg
Today 131,628 3-mo avg 366.5K
1W
292.1K
1M
341.5K
3M
366.5K
6M
380.6K
YTD
385.3K
1Y
386.0K

XGN most recently traded 131,628 shares against a 3-month average daily volume of 366.5K.

More News

Read More
News headline image
Exagen (XGN) Q2 2026 Earnings Call Transcript ↗
August 11, 2026
Via The Motley Fool
Topics Earnings Economy
News headline image
Exagen Q2 Earnings Call Highlights ↗
August 04, 2026
Via MarketBeat
Topics Artificial Intelligence Earnings
Exagen (NASDAQ:XGN) Beats Q2 Estimates and Raises Full-Year Guidance ↗
August 04, 2026
Via Chartmill
Exagen Inc. (NASDAQ:XGN) Soars on Q1 2026 Earnings Beat as Record Revenue and Narrowed Loss Fuel Pre-Market Rally ↗
May 11, 2026
Via Chartmill
Topics Earnings
Exagen Inc. (NASDAQ:XGN) Reports Record 2025 Revenue and Provides 2026 Outlook ↗
March 10, 2026
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
August 04, 2026
Via Chartmill
Top movers in Tuesday's session ↗
August 04, 2026
Via Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
August 04, 2026
Via Chartmill
Tuesday's pre-market session: top gainers and losers ↗
August 04, 2026
Via Chartmill
News headline image
Exagen Inc. Reports Second Quarter 2026 Financial Results
August 04, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Participate in Upcoming Investor Conference
July 28, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen to Announce Second Quarter Financial Results on August 4, 2026
July 21, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
June 01, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen (XGN) Q1 2026 Earnings Transcript ↗
May 12, 2026
Via The Motley Fool
News headline image
Exagen Q1 Earnings Call Highlights ↗
May 11, 2026
Via MarketBeat
Topics Earnings
News headline image
Exagen Inc. Reports First Quarter 2026 Results
May 11, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026
April 27, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results
March 10, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Participate in Upcoming Investor Conferences
March 03, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
February 24, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. Announces Select Preliminary 2025 Financial Results
January 11, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
November 11, 2025
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. (NASDAQ:XGN) Reports Mixed Q3 2025 Results with Revenue Beat and Wider-Than-Expected Loss ↗
November 04, 2025
Via Chartmill

Frequently Asked Questions

Is Exagen Inc. - Common Stock publicly traded?
Yes, Exagen Inc. - Common Stock is publicly traded.
What exchange does Exagen Inc. - Common Stock trade on?
Exagen Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exagen Inc. - Common Stock?
The ticker symbol for Exagen Inc. - Common Stock is XGN on the Nasdaq Stock Market
What is the current price of Exagen Inc. - Common Stock?
The current price of Exagen Inc. - Common Stock is 8.510
When was Exagen Inc. - Common Stock last traded?
The last trade of Exagen Inc. - Common Stock was at 11/04/26 04:00 PM ET
What is the market capitalization of Exagen Inc. - Common Stock?
The market capitalization of Exagen Inc. - Common Stock is 137.24M
How many shares of Exagen Inc. - Common Stock are outstanding?
Exagen Inc. - Common Stock has 137M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap